Swiss Exports to US See Sharp Decline Amid Trade Tensions

The numbers are in, and they paint a grim picture for the Swiss economy: exports to the United States have plummeted by a staggering 39.6%. This is not merely a dip; it is a collapse, marking the lowest export volume to our most critical trading partner since the dark days of late 2020. The Federal Office for Customs and Border Security (FOCBS) confirmed the shockwave on Thursday, revealing that total Swiss exports evaporated by 13.6% in May alone, falling to CHF 21.01 billion.

This dramatic downturn represents a brutal correction for Swiss manufacturers who have come to rely on American demand. While global trade often fluctuates, a drop of this magnitude signals a severe disruption in the transatlantic economic corridor. The data is unequivocal: the export engine that drives Swiss prosperity is sputtering, and the United States—usually a reliable consumer of Swiss precision and quality—has slammed on the brakes.

The writing was on the wall as early as March, when exports to the US doubled in a frantic rush to beat the clock. Swiss companies, anticipating the looming threat of "Trump tariffs," accelerated shipments at a breakneck pace, creating an artificial peak that has now given way to a deep valley. We are now witnessing the inevitable hangover from that pre-tariff binge. The "anticipatory effects" cited by analysts have played out exactly as feared: warehouses in the US are full, or the tariff hammer has made new shipments prohibitively expensive.

By April, the cracks were already visible with shipments falling by a third, but May's figures confirm the trend has solidified into a crisis. The volatility introduced by US trade policy is wreaking havoc on supply chain predictability. Swiss exporters, who thrived on the stability of open markets, are now grappling with a new reality where political maneuvering in Washington dictates the flow of goods from Basel and Zurich.

When the chemical-pharmaceutical industry sneezes, the entire Swiss economy catches a cold. In May, the sector didn't just sneeze; it contracted by a critical 19%. As the heavyweight champion of Swiss exports—accounting for more than half of all goods sold abroad—this double-digit decline is the primary driver behind the national trade slump. It is a stark reminder of our dangerous reliance on a single dominant sector.

The pain, however, is not exclusive to big pharma. The machinery and electronics sectors, long the backbone of Swiss SME innovation, are stagnating, unable to find growth momentum in the current climate. This widespread decline across key industries suggests that the rot is deep. With high-value goods failing to move, the ripple effects will likely be felt in production schedules and potential employment figures in the coming quarters.

Switzerland cannot look to its neighbors for salvation. Exports to Europe also fell by 7.2%, proving that the economic malaise is not confined to the Atlantic trade route. While Asia offered a glimmer of hope with a marginal 0.4% increase, it is nowhere near enough to offset the massive losses in the West. We are an export nation surrounded by cooling markets.

Compounding the issue, imports have continued to rise, ticking up by 0.8% to CHF 19.02 billion. The result is a rapidly shrinking trade surplus, now whittled down to just CHF 1.98 billion. As the buffer narrows, Switzerland faces a challenging second half of the year. The era of easy export growth appears to be over, replaced by a landscape of trade barriers and cooling demand that demands immediate strategic resilience from Swiss business leaders.